RGEN - Why Repligen Is Up More Than 10% Today
Shares of biotech company Repligen (NASDAQ: RGEN) are up an impressive 10.1% as of 11:15 a.m. ET Wednesday, according to data from S&P Global Market Intelligence . The rally is in response to the release of quarterly sales and earnings figures that both topped analysts' expectations.
For the three-month stretch ending in March, Repligen Corporation turned record-breaking revenue of $206.4 million into operating earnings of $0.92 per share. Organic revenue was up 44% year over year, while profits improved 35% compared to the year-ago operating bottom line of $0.68 per share. Analysts were only calling for sales of $185.5 million and earnings of $0.72 per share.
Image source: Getty Images.
For further details see:
Why Repligen Is Up More Than 10% Today